CBGV (cannabigerivarin) is a minor cannabinoid in cannabis that does not cause a high. It is the "varin" version of CBG: its side chain has three carbon atoms instead of five. The plant makes it as the acid CBGVA, which is also the starting point for THCV, CBDV and CBCV. Research on CBGV is so far limited to laboratory studies.
While CBD and THC still take the spotlight in most cannabinoid conversations, cannabigerivarin (CBGV) has started to attract more attention for its distinct structure and increasing presence in scientific circles.
After more than ten years working in the cannabis sector, especially with CBD and hemp, I have noticed a growing curiosity around cannabinoids that do not often make headlines. CBGV is one of these compounds and deserves a closer look.
In this article, I will cover what CBGV is, what sets it apart from other cannabinoids, where it comes from, how it interacts with the body’s endocannabinoid system and why it is becoming a topic of interest in research.
Drawing from what is currently known and what I have personally observed over the years, my aim is to give a straightforward and informative look at how CBGV fits into the wider picture of hemp-based compounds.
Prefer watching over reading? This video covers the key points from the article:
Key takeaways
- CBGV is a minor cannabinoid found in the cannabis plant, sharing structural similarities with CBG.
- It belongs to the varin-type class of cannabinoids, characterised by a propyl side chain.
- CBGV is non-psychoactive and does not produce intoxicating effects.
- This cannabinoid appears in lower concentrations and typically requires selective breeding for higher yields.
- Research into CBGV is ongoing, focusing on its role within the cannabinoid profile of hemp.
This article is provided for informational purposes only and does not relate to any of the products available in our online shop. For more information, please see our full disclaimer.
Understanding CBGV
Cannabigerivarin (CBGV) is a cannabinoid that has attracted interest in research because of its distinct chemical structure and its relationship to other compounds in the cannabis plant. Present in certain strains, CBGV stands out for its close structural ties to cannabinoids within the same family.
Examining its composition and the context of its discovery helps place CBGV more clearly within the broader cannabinoid spectrum.
Chemical composition and structure
The chemical formula of CBGV is C₁₉H₂₈O₂, with a molar mass of 288.431 g·mol⁻¹. Its structure features a benzene ring and a hydroxyl group, elements that may influence its interactions with biological targets. These traits define it as a varin-type cannabinoid.

Discovery and research background
CBGV was first identified in cannabis strains native to regions such as northwest India and Nepal. These natural plant samples served as the foundation for its classification as a distinct cannabinoid.
Initial studies drew attention to CBGV’s unique structure, distinguishing it from more familiar cannabinoids like CBD and THC. This difference has encouraged continued investigation into its potential role in the plant.
As a result, researchers began exploring how CBGV may interact with cannabinoid receptors such as CB1 and CB2. These early efforts laid the groundwork for ongoing studies that aim to clarify its characteristics under controlled research conditions.
CBGVA: where CBGV comes from
In the plant, CBGV starts as cannabigerovarinic acid (CBGVA). The plant forms it by joining divarinic acid with geranyl pyrophosphate, the same step that makes CBGA, except that the building block has a shorter chain. Enzymes can then turn CBGVA into the acid forms of THCV, CBDV and CBCV. Whatever is not converted becomes CBGV when heat removes the acid group, which is why CBGV is usually present only in small amounts.
Higher levels of varin cannabinoids have been reported mainly in some landrace varieties from Asia and Africa. Breeders can select plants with more varins, but measurable CBGV in a finished extract still depends on the variety and on testing.
How CBGV works: interaction with the endocannabinoid system
CBGV interacts with the endocannabinoid system (ECS), particularly with CB1 and CB2 receptors. Their relevance has made them central to ongoing cannabinoid research.
CB1 and CB2 receptor mechanism
Laboratory research has examined CBGV at human CB1 and CB2 receptors. Binding and functional results depend on the assay and reference ligand, so they should not be reduced to a general preference for one receptor over another or treated as proof of a benefit in humans. See this primary receptor study.
A publication in Frontiers in Pharmacology notes that CB1 and CB2 receptors regulate processes linked to neural activity and immune function.

The broader role of cannabinoid interactions
Beyond CB1 and CB2, researchers are studying whether CBGV also interacts with other molecular targets involved in cell signalling. These may include enzymes, ion channels and receptor systems outside the traditional cannabinoid framework.
Although the full range of these interactions is still being mapped, initial findings are helping to explain how cannabinoids like CBGV may act within complex biological environments. Laboratory-based studies remain essential for clarifying these dynamics under controlled conditions.
The endocannabinoid system (ECS)
CBGV (cannabigerivarin) extraction process
Extracting cannabigerivarin (CBGV) requires careful methods that isolate the cannabinoid while protecting its structure. Techniques such as CO2 and solvent-based extraction are the most widely used in cannabinoid processing facilities.
Common extraction techniques
Two of the most common methods for isolating CBGV include:
- CO2 extraction: This process uses supercritical carbon dioxide as a solvent to extract cannabinoids. Some processes also use an organic co-solvent such as ethanol. Extraction conditions and subsequent processing influence the composition of the extract; the method alone does not guarantee absence of residues or preservation of every compound.
- Solvent extraction: Ethanol and other organic solvents can be used to draw out cannabinoids, followed by evaporation steps to remove the solvent and refine purity.
Both methods are designed to protect the cannabinoid structure and reduce unwanted residues from plant materials or solvents.
CBG, the better-known relative of CBGV, is extracted with the same CO2 and ethanol methods: see how CBG oil is made.

Purity and quality control
Maintaining purity is essential during cannabinoid extraction. After processing, products undergo detailed quality checks for solvent residues, pesticides and heavy metals. These assessments help ensure the final extract meets safety and quality standards.
Risks and safety concerns of CBGV
As research into CBGV expands, its safety profile is still being developed. Current data suggest that CBGV is non-intoxicating, but there is little information available on long-term effects. Continued study is needed to establish a comprehensive safety record.
The future of CBGV in cannabinoid research
CBGV is gaining recognition because of its distinctive structure and potential interactions with other cannabinoids. Current investigations are exploring its possible roles in areas such as metabolism, neurobiology and broader plant compound research.
Preliminary findings suggest that CBGV may provide insights into how cannabinoids function within biological systems. Its uncommon profile continues to inform research directions in multiple fields.

Progress in genetic breeding and cultivation techniques is expected to improve the consistency of CBGV production in select hemp strains. These advances make it easier to conduct detailed research and support formulation work.
The way CBGV interacts with other cannabinoids remains a significant topic of study. Understanding these relationships may provide clearer insight into the broader function of minor cannabinoids within the cannabis plant.
Personal perspective
Over the years, working with hemp has shown me how much more there is to the plant than most people realise. CBD and THC tend to dominate the conversation, but occasionally, a lesser-known compound stands out. That is what happened with cannabigerivarin, or CBGV.
I came across it during day-to-day work in hemp processing, while examining the finer details of how these plants behave. Once you start noticing these smaller compounds, you realise they each have their own place within the wider cannabinoid profile.
CBGV sits within the wider mix of cannabinoids in a way that reflects the complexity of hemp. It may not be as widely known as CBD or THC, but it remains part of the plant’s broader chemical profile.
From my perspective, giving these lesser-known elements attention is part of understanding the plant properly. The full picture does not come from only looking at the most familiar compounds. CBGV may be a minor cannabinoid, but it contributes to what makes the plant scientifically interesting.
Frequently asked questions
What is CBGV (cannabigerivarin)?
CBGV stands for cannabigerivarin, a lesser-known cannabinoid found in the cannabis plant. It is structurally similar to cannabigerol (CBG) but is classified as a varin-type cannabinoid due to a shorter side chain.
How is CBGV different from CBG?
CBGV contains a propyl side chain, while CBG has a pentyl side chain. This minor difference places CBGV in the varin subgroup, which may influence its behaviour in plant biosynthesis.
Is CBGV psychoactive?
No, CBGV is non-psychoactive. It does not produce the intoxicating effects associated with cannabinoids like THC.
Where is CBGV found in the cannabis plant?
CBGV typically appears in trace amounts and is more prevalent during the early stages of plant development. Certain hemp strains may express higher levels of CBGV due to selective breeding.
What is the relationship between CBGV and other cannabinoids?
CBGV belongs to the propyl-side-chain branch of cannabinoid biosynthesis. Its acidic precursor is cannabigerovarinic acid (CBGVA), while cannabigerolic acid (CBGA) is the acidic precursor of CBG. Decarboxylation converts these acids into their corresponding neutral cannabinoids, CBGV and CBG, respectively. See the separate pathways in Figure 4 of Shaw et al. (2022).
Can CBGV be extracted from hemp?
Yes, CBGV can be extracted using standard processes such as supercritical CO₂ or ethanol extraction. However, due to its lower concentration, it may require additional refinement steps.
Does CBGV contribute to the entourage effect?
CBGV is thought to interact with other plant compounds, including cannabinoids and terpenes, in ways that may influence overall outcomes. This interaction is commonly referred to as the entourage effect.
Is CBGV legal?
CBGV’s legal position depends on the jurisdiction, the product’s composition and its intended category of use. Hemp origin and a low THC content alone do not establish that a product may be sold. Drug-control requirements and rules for foods, medicines or cosmetics must be assessed separately for the particular product and market. See the European Commission’s statement on cannabinoids in foods and the UK guidance distinguishing cannabinoid substances from finished products.
Are there specific strains rich in CBGV?
Some hemp varieties have been selectively bred to enhance levels of minor cannabinoids like CBGV. These are often developed for research or product formulation purposes.
How does CBGV compare to THC or CBD?
Unlike THC, CBGV is not intoxicating. Compared to CBD, it occurs in smaller amounts and is less well studied. Researchers are actively investigating its characteristics to better understand its function in the plant.
Curious how CBGV compares? Read our quick guide: what is CBG?